JPS63196576A - Furalnaphthoquinone derivative and carcinostatic agent and production thereof - Google Patents

Furalnaphthoquinone derivative and carcinostatic agent and production thereof

Info

Publication number
JPS63196576A
JPS63196576A JP2859587A JP2859587A JPS63196576A JP S63196576 A JPS63196576 A JP S63196576A JP 2859587 A JP2859587 A JP 2859587A JP 2859587 A JP2859587 A JP 2859587A JP S63196576 A JPS63196576 A JP S63196576A
Authority
JP
Japan
Prior art keywords
furalnaphthoquinone
tables
formulas
formula
chemical formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2859587A
Other languages
Japanese (ja)
Inventor
Tetsuo Ikegawa
哲郎 池川
Nobuo Ikegawa
池川 信夫
Masuo Tsukada
塚田 益男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2859587A priority Critical patent/JPS63196576A/en
Publication of JPS63196576A publication Critical patent/JPS63196576A/en
Pending legal-status Critical Current

Links

Landscapes

  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A furalnaphthoquinone derivative expressed by formula I (R is -OR', -R', formula II or III; R' is H, alkyl or hydroxyalkyl). EXAMPLE:1-(1-Hydroxyethyl)-furalnaphthoquinone. USE:With powerful carcinostatic activity and useful as a carcinostatic agent. PREPARATION:Tree barks of Tabebuia avellanedal Lorenz or Tebebuia impetiginosa of the family Biognoniaceae unique to Sotth America are extracted with lower alcohols, such as methanol, etc., and the resultant extract is then adjusted to pH 8 and distributed with aqueous butanol to separate a butanol extract, which is subsequently subjected to column chromatography using silica gel and purified to afford the aimed compound expressed by formula I.

Description

【発明の詳細な説明】 氏名   塚 1)益 男[Detailed description of the invention] Name Tsuka 1) Masu Oo

Claims (3)

【特許請求の範囲】[Claims] (1)次の一般式 ▲数式、化学式、表等があります▼ (式中Rは−OR′、−R′、▲数式、化学式、表等が
あります▼、▲数式、化学式、表等があります▼で R′は水素原子、アルキル基及び/又はハイドロオキシ
アルキル基)で表わされるフラルナフトキノン誘導体。
(1) The following general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R is -OR', -R', ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼, ▲ There are mathematical formulas, chemical formulas, tables, etc. In ▼, R' is a hydrogen atom, an alkyl group and/or a hydroxyalkyl group), and is a furalnaphthoquinone derivative.
(2)次の一般式 ▲数式、化学式、表等があります▼ (式中Rは−OR′、−R′、▲数式、化学式、表等が
あります▼、▲数式、化学式、表等があります▼で R′は水素原子、アルキル基及び/又はハイドロオキシ
アルキル基)で表わされるフラルナフトキノン誘導体を
有効成分とする制癌剤。
(2) The following general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R is -OR', -R', ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼, ▲ There are mathematical formulas, chemical formulas, tables, etc. An anticancer drug containing a furalnaphthoquinone derivative represented by ▼ (where R' is a hydrogen atom, an alkyl group, and/or a hydroxyalkyl group) as an active ingredient.
(3)高等植物イッペイ・ホッシュを有機溶媒又は水で
抽出し、クロマトグラフによる精製工程を経て次の一般
式で表わされるフラルナフトキノン誘導体を製造する方
法。 ▲数式、化学式、表等があります▼ (式中Rは−OR′、−R′、▲数式、化学式、表等が
あります▼、▲数式、化学式、表等があります▼で R′は水素原子、アルキル基及び/又はハイドロオキシ
アルキル基)
(3) A method for producing a furalnaphthoquinone derivative represented by the following general formula by extracting the higher plant Ippei Hosch with an organic solvent or water and performing a chromatographic purification process. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R is -OR', -R', ▲There are mathematical formulas, chemical formulas, tables, etc.▼, ▲There are mathematical formulas, chemical formulas, tables, etc.▼ and R' is a hydrogen atom , alkyl group and/or hydroxyalkyl group)
JP2859587A 1987-02-10 1987-02-10 Furalnaphthoquinone derivative and carcinostatic agent and production thereof Pending JPS63196576A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2859587A JPS63196576A (en) 1987-02-10 1987-02-10 Furalnaphthoquinone derivative and carcinostatic agent and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2859587A JPS63196576A (en) 1987-02-10 1987-02-10 Furalnaphthoquinone derivative and carcinostatic agent and production thereof

Publications (1)

Publication Number Publication Date
JPS63196576A true JPS63196576A (en) 1988-08-15

Family

ID=12252944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2859587A Pending JPS63196576A (en) 1987-02-10 1987-02-10 Furalnaphthoquinone derivative and carcinostatic agent and production thereof

Country Status (1)

Country Link
JP (1) JPS63196576A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006786A1 (en) * 1992-09-18 1994-03-31 Taheebo Japan Co., Ltd. 2-(1-HYDROXYETHYL)-5-HYDROXYNAPHTO[2,3-b]FURAN-4,9-DIONE AND ANTITUMOR AGENTS COMPRISING THIS COMPOUND
US7538234B2 (en) 2007-05-31 2009-05-26 Taheebo Japan Co., Ltd. Preparation of Optically active 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4, 9-diones having anticancer activities
JP2010539095A (en) * 2007-09-10 2010-12-16 ボストン バイオメディカル, インコーポレイテッド Novel Stat3 pathway inhibitor and cancer stem cell inhibitor
US7910752B2 (en) 2005-03-16 2011-03-22 Taheebo Japan Co., Ltd. Anticancer compound, intermediate therefor, and processes for producing these
CN107973788A (en) * 2018-01-09 2018-05-01 沈阳药科大学 BBI608 derivatives and its preparation and purposes
WO2018096401A1 (en) 2016-11-22 2018-05-31 Hitoshi Ban New naphtho[2,3-b]furan derivatives
US10017488B2 (en) 2014-02-07 2018-07-10 Boston Biomedical, Inc. 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
US10543189B2 (en) 2013-04-09 2020-01-28 Boston Biomedical, Inc. 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
US10646464B2 (en) 2017-05-17 2020-05-12 Boston Biomedical, Inc. Methods for treating cancer
WO2020161959A1 (en) * 2019-02-06 2020-08-13 タヒボジャパン株式会社 Naphthoquinone compound having antibacterial and antiviral activities and pharmaceutical use thereof
US10906914B2 (en) 2015-01-08 2021-02-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Furoquinolinediones as inhibitors of TDP2
US10934309B2 (en) 2014-03-31 2021-03-02 Sumitomo Dainippon Pharma Oncology, Inc. Tricyclic quinone derivative
US11299469B2 (en) 2016-11-29 2022-04-12 Sumitomo Dainippon Pharma Oncology, Inc. Naphthofuran derivatives, preparation, and methods of use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TETRAHEDRON LETTERS=1986 *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06145162A (en) * 1992-09-18 1994-05-24 Tahibo Japan Kk 2-@(3754/24)1-hydroxyethyl-5-hydroxynaphtho(2,3-b) furan-4,5-dione and anticancer medicine containing the same
WO1994006786A1 (en) * 1992-09-18 1994-03-31 Taheebo Japan Co., Ltd. 2-(1-HYDROXYETHYL)-5-HYDROXYNAPHTO[2,3-b]FURAN-4,9-DIONE AND ANTITUMOR AGENTS COMPRISING THIS COMPOUND
US7910752B2 (en) 2005-03-16 2011-03-22 Taheebo Japan Co., Ltd. Anticancer compound, intermediate therefor, and processes for producing these
US7538234B2 (en) 2007-05-31 2009-05-26 Taheebo Japan Co., Ltd. Preparation of Optically active 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4, 9-diones having anticancer activities
US10377731B2 (en) 2007-09-10 2019-08-13 Boston Biomedical, Inc. Compositions and methods for cancer treatment
JP2010539095A (en) * 2007-09-10 2010-12-16 ボストン バイオメディカル, インコーポレイテッド Novel Stat3 pathway inhibitor and cancer stem cell inhibitor
CN105963289A (en) * 2007-09-10 2016-09-28 北京强新生物科技有限公司 Novel group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors
US10851075B2 (en) 2007-09-10 2020-12-01 Sumitomo Dainippon Pharma Oncology, Inc. Stat3 pathway inhibitors and cancer stem cell inhibitors
US10543189B2 (en) 2013-04-09 2020-01-28 Boston Biomedical, Inc. 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
US10017488B2 (en) 2014-02-07 2018-07-10 Boston Biomedical, Inc. 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
US10683274B2 (en) 2014-02-07 2020-06-16 Boston Biomedical, Inc. 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
US10934309B2 (en) 2014-03-31 2021-03-02 Sumitomo Dainippon Pharma Oncology, Inc. Tricyclic quinone derivative
US10906914B2 (en) 2015-01-08 2021-02-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Furoquinolinediones as inhibitors of TDP2
WO2018096401A1 (en) 2016-11-22 2018-05-31 Hitoshi Ban New naphtho[2,3-b]furan derivatives
US11299469B2 (en) 2016-11-29 2022-04-12 Sumitomo Dainippon Pharma Oncology, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
US10646464B2 (en) 2017-05-17 2020-05-12 Boston Biomedical, Inc. Methods for treating cancer
CN107973788A (en) * 2018-01-09 2018-05-01 沈阳药科大学 BBI608 derivatives and its preparation and purposes
WO2020161959A1 (en) * 2019-02-06 2020-08-13 タヒボジャパン株式会社 Naphthoquinone compound having antibacterial and antiviral activities and pharmaceutical use thereof

Similar Documents

Publication Publication Date Title
JPS63196576A (en) Furalnaphthoquinone derivative and carcinostatic agent and production thereof
KR830006174A (en) Bronchial Anticonvulsant Compounds
ATE44954T1 (en) CARBOSTYRIL DERIVATIVE AND PROCESS FOR ITS PRODUCTION.
RU95112577A (en) 1,4-disubstituted piperazines useful for asthma and respiratory ways inflammation treatment, method of their synthesis, medicinal preparations made of their base and method of their preparing
ES2183492T3 (en) NEW NITRON DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPS62142181A (en) Novel tannin
JPH10501518A (en) Antimalarial colpensamine, pharmaceutical composition and pharmaceutical use thereof
FI101222B1 (en) Process for the preparation of therapeutically active quinolin-2-ylmethoxyphenyl derivatives
EP1487825A1 (en) Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities
FR2470110A1 (en) DECRAPENYLAMINE DERIVATIVES, THEIR ACID ADDITION SALTS AND PHARMACEUTICAL COMPOSITION COMPRISING THESE PRODUCTS
JP3055846B2 (en) Antioxidant
CN102718818A (en) Nitrogenous troxerutin derivative, preparation method thereof and application
DE69020377D1 (en) Process for the preparation of environmentally harmless dicofol and its formulations.
JPS5610188A (en) Xanthine derivative and its preparation
JPH0260680B2 (en)
JPS59184158A (en) Clavulone derivative
JP2006514970A (en) Hepatoprotective pharmaceutical composition containing a mixture of comarinolignoids and method for preparing the same
JPS63130548A (en) Hydroquinone derivative
JPS62108858A (en) Trans-n-(2-hydroxyethyl)-3-methylthiopropenamide
JPH06256353A (en) Glabridin derivative
CN108440479A (en) A kind of extracting method of flavanones
JPS57163373A (en) Sesquiterpenoid compound, its preparation, and antihepatitis agent comprising it as active ingfedient
JPH0296579A (en) Alkaloid compound, drug composition and use thereof
JPS6035343B2 (en) 2-methylbenzimidazole derivatives and insecticides containing the same
JPS61112080A (en) Novel tannin